Overview

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Status:
Recruiting
Trial end date:
2021-12-14
Target enrollment:
Participant gender:
Summary
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.
Phase:
Phase 3
Details
Lead Sponsor:
Orasis Pharmaceuticals Ltd.